We are the lung research center of the Leibniz Association. Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
The program area is dedicated to research into asthma, COPD and allergies, as these are among the most common chronic diseases and therefore cause an enormous burden for both patients and healthcare systems.
The Infections program area is dedicated to researching and combating bacterial infectious diseases of the lung with a focus on tuberculosis. The aim is to improve the control and treatment of this disease.
38. Allergiekolloquium in Borstel: Interdisziplinärer Austausch mit neuen Impulsen
Am 18. April 2026 kamen rund 60 Teilnehmende zum 38. Allergiekolloquium im Herrenhaus des Forschungszentrums Borstel, Leibniz Lungenzentrum zusammen. Die traditionsreiche Veranstaltung erwies sich erneut als voller Erfolg und bestätigte ihren Ruf als renommierte Plattform der Allergologie, die weit über die Grenzen Schleswig-Holsteins hinaus bekannt ist.
24.04.2026
20 Years of TBnet: Two decades of unparalleled cross-border collaboration in tuberculosis research and education
Tuberculosis is the leading cause of death by a single micro-organism. On April 21st 2026, leading tuberculosis researchers from across Europe and beyond gathered at the Max von Pettenkofer Institute in Munich to celebrate the 20th anniversary of the Tuberculosis Network European Trials group (TBnet), marking two decades of sustained scientific collaboration, innovation, and education in the fight against tuberculosis. T
14.04.2026
Long-term cure rates for multidrug-resistant tuberculosis much better than expected
A new national cohort study from Latvia, conducted in collaboration with researchers from the clinical tuberculosis infrastructure (ClinTB) at the German Centre for Infection Research (DZIF) at the Research Centre Borstel, Leibniz Lung Centre (FZB), provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB).
Prof. Dr. Stefan Niemann
FG Gruppe_en: Molecular and Experimental Mycobacteriology
Contact
Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.